These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15264432)

  • 41. Using genetic variation to optimize cancer chemotherapy.
    McLeod HL; Papageorgio C; Watters JW
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):107-11. PubMed ID: 16224389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy.
    Marsh S; Liu G
    Adv Drug Deliv Rev; 2009 May; 61(5):381-7. PubMed ID: 19100797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?
    Brenton JD; Carey LA; Ahmed AA; Caldas C
    J Clin Oncol; 2005 Oct; 23(29):7350-60. PubMed ID: 16145060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer.
    Bernig T; Chanock SJ
    Expert Rev Mol Diagn; 2006 May; 6(3):319-31. PubMed ID: 16706736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacogenomics and breast cancer.
    Lymberis SC; Parhar PK; Katsoulakis E; Formenti SC
    Pharmacogenomics; 2004 Jan; 5(1):31-55. PubMed ID: 14683419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going.
    Rosell R; Cuello M; Cecere F; Santarpia M; Reguart N; Felip E; Taron M
    Curr Opin Oncol; 2006 Mar; 18(2):135-43. PubMed ID: 16462182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Technology insight: Emerging techniques to predict response to preoperative chemotherapy in breast cancer.
    Pusztai L; Gianni L
    Nat Clin Pract Oncol; 2004 Nov; 1(1):44-50. PubMed ID: 16264799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene expression profiling in breast cancer: towards individualising patient management.
    Murphy N; Millar E; Lee CS
    Pathology; 2005 Aug; 37(4):271-7. PubMed ID: 16194824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacogenomics: state of the research and perspectives in clinical application.
    Severino G; Chillotti C; Stochino ME; Del Zompo M
    Neurol Sci; 2003 May; 24 Suppl 2():S146-8. PubMed ID: 12811615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted therapy and pharmacogenomic programs.
    Iqbal S; Lenz HJ
    Cancer; 2003 Apr; 97(8 Suppl):2076-82. PubMed ID: 12673699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pharmacogenomics in chemotherapy and drug development for breast cancer].
    Shimizu C; Fujiwara Y
    Nihon Rinsho; 2006 Mar; 64(3):424-31. PubMed ID: 16529031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent advances in the pharmacogenetics of cancer chemotherapy.
    Watters JW; McLeod HL
    Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas.
    Shai RM; Reichardt JK; Chen TC
    Future Oncol; 2008 Aug; 4(4):525-34. PubMed ID: 18684063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Genetic variations affect drug safety and efficacy].
    Harmsze AM; Deneer VH; Maitland-van der Zee AH; de Boer A; Klungel OH
    Ned Tijdschr Geneeskd; 2010; 154():A1503. PubMed ID: 20699026
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
    Slonim DK
    Pharmacogenomics; 2001 May; 2(2):123-36. PubMed ID: 11368751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.